Correction: EZH2 -Deficient T-Cell Acute Lymphoblastic Leukemia is Sensitized to CHK1 Inhibition Through Enhanced Replication Stress

IF 29.5 1区医学 Q1 ONCOLOGY

Cancer discovery Pub Date : 2026-10-01 DOI:10.1158/2159-8290.cd-26-1718

Theresa E. León,Tanya Rapoz-D’Silva,Cosetta Bertoli,Sunniyat Rahman,Michael Magnussen,Brian Philip,Nadine Farah,Simon E. Richardson,Sara Ahrabi,José Afonso Guerra-Assunção,Rajeev Gupta,Elisabeth P. Nacheva,Stephen Henderson,Javier Herrero,David C. Linch,Robertus A.M. de Bruin,Marc R. Mansour

引用次数: 0

查看原文本刊更多论文

更正：EZH2缺陷t细胞急性淋巴细胞白血病通过增强复制应激对CHK1抑制敏感

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer discovery ONCOLOGY-

CiteScore

22.90

自引率

1.40%

发文量

838

审稿时长

6-12 weeks

期刊介绍： Cancer Discovery publishes high-impact, peer-reviewed articles detailing significant advances in both research and clinical trials. Serving as a premier cancer information resource, the journal also features Review Articles, Perspectives, Commentaries, News stories, and Research Watch summaries to keep readers abreast of the latest findings in the field. Covering a wide range of topics, from laboratory research to clinical trials and epidemiologic studies, Cancer Discovery spans the entire spectrum of cancer research and medicine.